PMC3350113_01
Prostate adenocarcinoma from biopsy (hematoxylin and eosin, 200x).
CRIM.ONCMED2011-864371.001.jpg
PMC3350113_01_CRIM.ONCMED2011-864371.001.jpg
fig1
The patient was a 68-year-old human-immunodeficiency virus- (HIV-) negative African-American male who presented for consideration of radiation therapy for prostate cancer: clinical stage T1c, Gleason score 4 + 3 = 7 (Figures 1 and 2), prostate specific antigen (PSA) 14.5 nanogram/deciliter.
Prostate adenocarcinoma from biopsy (hematoxylin and eosin, 400x).
CRIM.ONCMED2011-864371.002.jpg
PMC3350113_01_CRIM.ONCMED2011-864371.002.jpg
fig2
The patient was a 68-year-old human-immunodeficiency virus- (HIV-) negative African-American male who presented for consideration of radiation therapy for prostate cancer: clinical stage T1c, Gleason score 4 + 3 = 7 (Figures 1 and 2), prostate specific antigen (PSA) 14.5 nanogram/deciliter.
Squamous cell carcinoma in situ of the anus with underlying invasion from biopsy (hematoxylin and eosin, 200x).
CRIM.ONCMED2011-864371.003.jpg
PMC3350113_01_CRIM.ONCMED2011-864371.003.jpg
fig3
Evaluation via physical exam, colonoscopy, and biopsy revealed a 1.5 centimeter invasive squamous cell carcinoma (Figure 3) at the anorectal junction.